|
|
|
|
|
|
| The Proposed Acquisition will enable Asia Vets Holdings to capture opportunities within the fast-growing financial and technology business and achieve higher revenue levels alongside their existing business |
SINGAPORE, Jan 3, 2022 - (ACN Newswire) - Catalist-listed Asia Vets Holdings Ltd. ("Asia Vets Holdings", the "Company", and together with its subsidiaries, the "Group") has entered into a conditional sale and purchase agreement ("SPA") with RHT AlDigi Financial Holdings Pte. Ltd. ("Vendor") and AlDigi Holdings Pte. Ltd. (the "AlDigi Group" or the "Target") on 30th December 2021 to acquire from the Vendor 100% of the ordinary shares in the issued and paid-up share capital of the Target (the "Proposed Acquisition").
 | | Tan Chong Huat, Chairman of RHT Group of Companies, Tan Tong Guan, Executive Chairman and Chief Executive Officer of Asia Vets Holdings Ltd., and Jayaprakash Jagateesan, Chief Executive Officer of AlDigi Holdings Pte. Ltd. at the signing ceremony. [L-R] |
The S$45 million consideration for the Proposed Acquisition shall be satisfied by way of allotment and issuance of 335,436,357 new ordinary shares ("Consideration Shares") in the capital of the Company at the issue price of approximately S$0.13415 per Consideration Share. The Proposed Acquisition, subject to, inter alia, the approval of the Company's shareholders, adds an additional revenue stream as well as an opportunity to diversify the Group's portfolio of businesses. The Company also believes that the Proposed Acquisition has the potential to increase the market capitalisation and widen the investor base of the Company.
Mr Tan Tong Guan, Asia Vets Holdings Executive Chairman and Chief Executive Officer, said, "We have been actively exploring various acquisition opportunities to maximise value for shareholders and enable the Company to achieve higher revenue levels. The Proposed Acquisition, when completed, is expected to enable us to capture opportunities within the fast-growing financial and technology business and we are confident of the industry's significant long-term growth prospects."
The Target's subsidiaries are digital finance and technology firm RHT DigiCapital Pte. Ltd., intellectual property consultancy RHT i-Assets Advisory Pte. Ltd., and its proposed subsidiary, capital markets advisory firm RHT Capital Pte. Ltd. (collectively with the Target, the "Target Group").
The Proposed Acquisition will enable the Company to build on the Target Group's established continuing sponsorship and licenced corporate finance business to develop new digital solutions to serve both traditional and digital finance markets.
Mr Jayaprakash Jagateesan, AlDigi Group Chief Executive Officer, said, "We have developed a fintech platform to reshape the capital markets to become the gateway to diverse digital assets and investments, built on a commitment to enhancing efficiency, accessibility and equal opportunity across capital markets and alternative investments. The Proposed Acquisition will further accelerate our efforts to develop new innovative products to capture the fast-growing digital security token economy with a focus on real estate, non-fungible tokens, and environmental, social and governance investments."
Post-completion of the Proposed Acquisition, the Group will continue to own and operate its veterinary business.
This media release is to be read in conjunction with the full text of the Company's announcement dated 30 December 2021 released on SGXNET, in relation to the proposed acquisition.
About Asia Vets Holdings Ltd. (SGX:5RE) (www.asiavets.com)
Asia Vets Holdings Ltd. (the "Company"), through its wholly-owned subsidiary, AVH Animal Ark Pte. Ltd. (together with the Company, the "Group"), provides veterinary care and clinical services to small animals in Singapore.
The Group currently operates two veterinary clinics providing a full range of general veterinary services including medical, surgical and dental care for small animals and after-hours emergency services.
About AlDigi Holdings Pte. Ltd. (www.aldigi.co)
The AlDigi Group combines proven expertise and deep experience across capital markets, blockchain technology and intellectual property to deliver next-gen digital finance solutions through the following subsidiaries/ proposed subsidiaries:
- RHT Capital
- RHT DigiCapital
- RHT i-Assets Advisory
The AlDigi Group leverages its proven proprietary institutional grade technology to deliver digital asset solutions across multiple asset classes and sought-after alternative investment products. As part of the ONE RHT ecosystem of multidisciplinary professional services, the AlDigi Group has access to a wide range of expertise including sustainability to add value to its digital asset solutions.
Issued on behalf of Asia Vets Holdings Ltd.
For media enquiries, please contact:
Elliot Siow
Communications Manager
RHT Communications & Investor Relations Pte. Ltd.
DID: +65 6381 6347
Email: elliot.siow@rhtgoc.com
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor"), in accordance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor Ms Alice Ng, Director of Continuing Sponsorship, ZICO Capital Pte. Ltd. at 8 Robinson Road, #09-00 ASO Building, Singapore 048544, telephone +65 6636 4201.
Topic: Press release summary
Source: Asia Vets Holdings
Sectors: Daily Finance, Local Biz, FinTech
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
Latest Press Releases
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 6, 2026 17:45 HKT/SGT
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 17:01 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 14:17 HKT/SGT
|
|
|
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025
Feb 6, 2026 13:13 HKT/SGT
|
|
|
Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market
Friday, February 6, 2026 12:34:00 PM
|
|
|
Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market
Feb 6, 2026 12:21 HKT/SGT
|
|
|
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors
Feb 6, 2026 11:44 HKT/SGT
|
|
|
Establishment of the World's First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony's High-Performance Products
Friday, February 6, 2026 10:50:00 AM
|
|
|
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
Friday, February 6, 2026 10:31:00 AM
|
|
|
|
|
More Press release >> |
|
|
|
